Evidence map›Paper›PMID 28540173›Full record

ArticleActa pharmaceutica Sinica. B2017

Self-microemulsifying drug delivery system for improving the bioavailability of huperzine A by lymphatic uptake.

Fang Li, Rongfeng Hu, Bin Wang, Yun Gui, Gang Cheng, Song Gao, Lei Ye, Jihui Tang

Open access · diamondAbstract read
In one paragraph

Article in Acta pharmaceutica Sinica. B, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 96 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. An update on oral drug deliveryActa pharmaceutica Sinica. B · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Fang LiAnhui University of Chinese Medicine, Hefei 230038, China.
Rongfeng HuAnhui University of Chinese Medicine, Hefei 230038, China.
Bin WangAnhui University of Chinese Medicine, Hefei 230038, China.
Yun GuiAnhui University of Chinese Medicine, Hefei 230038, China.
Gang ChengAnhui University of Chinese Medicine, Hefei 230038, China.
Song GaoAnhui University of Chinese Medicine, Hefei 230038, China.
Lei YeAnhui University of Chinese Medicine, Hefei 230038, China.
Jihui TangSchool of Pharmacy, Anhui Medical University, Hefei 230022, China.
Ministry of Education of the People's Republic of China · CNAnhui University of Traditional Chinese Medicine · CNAnhui Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Huperzine A (Hup-A) is a poorly water-soluble drug with low oral bioavailability. A self-microemulsifying drug delivery system (SMEDDS) was used to enhance the oral bioavailability and lymphatic uptake and transport of Hup-A. A single-pass intestinal perfusion (SPIP) technique and a chylomicron flow-blocking approach were used to study its intestinal absorption, mesenteric lymph node distribution and intestinal lymphatic uptake. The value of the area under the plasma concentration-time curve (AUC) of Hup-A SMEDDS was significantly higher than that of a Hup-A suspension (

Indexed as

BioavailabilityDrug delivery systemsHuperzine ALymphatic transportSelf-microemulsionSingle-pass intestinal perfusionSMEDDS

Identifiers

PMID28540173
PMCPMC5430757
OpenAlexW2591861763

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.